NEW YORK CITY, NY / ACCESS Newswire / March 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds ...

The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine sales falling, some market participants say it may draw in activist ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...

So, one of the milestones that I want to note right at the beginning of the article is that GSK announced that on January 28, 2025, regulatory authorities in China, Japan, and Europe accepted ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... whether they will hire more people in the US compared to Europe or Asia and whether they will bring back more business ...

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 years, the company said on ...

GSK PLC on Monday said the European Medicines Agency accepted for review its application for an alternative treatment ... Subscribe now to see this Premium News article from Alliance News ...

Sales in Europe rose 10%, while that in International markets rose 8% at CER. All growth rates mentioned below are on a year-on-year basis and at CER. GSK reports under three segments: Specialty ...